Abstract | CONCLUSIONS: OBJECTIVES: PATIENTS AND METHODS: Patients treated for T2-T4 carcinoma or a recurrence after T1 who visited the outpatient clinic for their regular follow-up visit were included. All patients were evaluated for the development of hypothyroidism, defined as increased thyroid-stimulating hormone level (>4.5 mU/L) and the presence of autoantibodies. A questionnaire regarding symptoms was administered. RESULTS:
|
Authors | Annalisa M Lo Galbo, Remco de Bree, Dirk J Kuik, Paul Th A M Lips, B Mary, E Von Blomberg, Johannes A Langendijk, C Rene Leemans |
Journal | Acta oto-laryngologica
(Acta Otolaryngol)
Vol. 127
Issue 3
Pg. 312-7
(Mar 2007)
ISSN: 0001-6489 [Print] England |
PMID | 17364370
(Publication Type: Journal Article)
|
Chemical References |
- Autoantibodies
- LINC00273 lncRNA, human
- Membrane Glycoproteins
- RNA, Long Noncoding
- Thyrotropin
- Thyroglobulin
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Autoantibodies
(blood)
- Combined Modality Therapy
- Cross-Sectional Studies
- Female
- Humans
- Hypopharyngeal Neoplasms
(pathology, radiotherapy, surgery)
- Hypothyroidism
(epidemiology, etiology)
- Laryngeal Neoplasms
(pathology, radiotherapy, surgery)
- Male
- Membrane Glycoproteins
(immunology)
- Middle Aged
- Multivariate Analysis
- Neoplasm Staging
- Postoperative Complications
(epidemiology, etiology)
- Prognosis
- RNA, Long Noncoding
- Radiotherapy, Adjuvant
- Risk Factors
- Thyroglobulin
(immunology)
- Thyroidectomy
- Thyrotropin
(blood)
|